“Outcome of non-surgical periodontal treatment on Gal-1 and Gal-3 GCF levels in periodontitis patients: a case-control study”
Clinical Oral Investigations · 2024
DOI: 10.1007/s00784-024-05688-1 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Clinical Oral Investigations, 2024. Verfasst von Nayroz Abdel Fattah Tarrad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oral Medicine and Periodontology Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt. nam05@fayoum.edu.eg. Hauptthemen laut MEDLINE: Biomarkers, Periodontitis, Gingival Crevicular Fluid, Galectin 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fayoum University.
Abstract (Originalsprache)
Objectives
This study aimed to explore the effect of nonsurgical periodontal treatment on Galectin-1 and -3 GCF levels in gingivitis and periodontitis stage III compared to periodontally healthy individuals, to determine whether they could serve as diagnostic markers / therapeutic targets for periodontitis and revealing their possible role in periodontal disease. Materials and methods Forty-five systemically healthy participants were included and equally subdivided into three groups: gingivitis, periodontitis (stage III), and a periodontally healthy control group. The clinical parameters were recorded. Galectin-1 and -3 GCF levels were evaluated (before and after non-surgical treatment for periodontitis) using an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value, and diagnostic accuracy of both markers.
Results
The study showed statistical significance between different groups regarding Galectin-3 with higher values in periodontitis and the lowest values in healthy control. Also, Galectin-1 was significantly higher in the periodontitis/gingivitis groups than in the control group. Moreover, non-surgical periodontal treatment in periodontitis patients caused a statistical reduction in clinical parameters and biomarkers. ROC analysis revealed excellent diagnostic ability of both biomarkers in discriminating periodontitis/gingivitis against healthy individuals (100% diagnostic accuracy for Galectin-1 and 93% for Galectin-3, AUC > 0.9) and acceptable diagnostic ability between periodontitis participants against gingivitis (73% diagnostic accuracy for Gal-1 and 80% for Gal-3, AUC > 0.7).
Conclusions
Both Galectin-1 and Galectin-3 seem to have outstanding diagnostic accuracy for the identification of periodontal disease, an acceptable ability to measure periodontal disease activity and the severity of inflammatory status. Additionally, they could serve as therapeutic targets to monitor treatment efficiency. Clinicaltrial.gov registration number (NCT06038812).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oral Medicine and Periodontology Department, Faculty of Dentistry, Fayoum University, Fayoum, Egypt. nam05@fayoum.edu.eg.
- Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
- Oral Medicine and Periodontology Department, Faculty of Dentistry, Beni-Suef University, Beni-Suef, Egypt.
Förderung
- Fayoum University
Zitieren
APA
Tarrad, N. A. F., Shaker, O. G., Elbanna, R. M. H., & AbdelKawy, M. (2024). “Outcome of non-surgical periodontal treatment on Gal-1 and Gal-3 GCF levels in periodontitis patients: a case-control study”. Clinical Oral Investigations. https://doi.org/10.1007/s00784-024-05688-1
Vancouver
Tarrad NAF, Shaker OG, Elbanna RMH, AbdelKawy M. “Outcome of non-surgical periodontal treatment on Gal-1 and Gal-3 GCF levels in periodontitis patients: a case-control study”. Clinical Oral Investigations. 2024. doi:10.1007/s00784-024-05688-1
BibTeX
@article{Tarrad2024,
author = {Tarrad, Nayroz Abdel Fattah and Shaker, Olfat Gamil and Elbanna, Riham Mohamed Hassan and AbdelKawy, Maha},
title = {“Outcome of non-surgical periodontal treatment on Gal-1 and Gal-3 GCF levels in periodontitis patients: a case-control study”},
journal = {Clinical Oral Investigations},
year = {2024},
doi = {10.1007/s00784-024-05688-1}
}
EUVIMED